(TheNewswire)
Calgary, Alberta - TheNewswire - September 25, 2023 - nDatalyze Corp. (CSE:NDAT) (“ NDAT ” or the “ Corporation ”) announces that it has grantedan aggregate of 3,150,000 stock options to its directors, officers andconsultants pursuant to the Corporation’s stock option plan, at anexercise price of $0.08 per common share and expiring two years fromthe date of grant. The stock options are subject to a customary fourmonth hold period from the date of grant.
ABOUT NDATALYZE CORP:
Ndatalyze generates technology-based, health-relatedsolutions. Its machine-learning-processed, on-line mental healthapplication, known as YMI, is based on the Corporation's proprietaryreference database consisting of more than 1,200 biometric records,complete with associated electroencephalogram (EEG) data. YMI has onlyrecently begun its initial staged launch and, accordingly, theCorporation cannot accurately predict if or when this application willbecome a profit generator.
About YMI
YMI uses a holistic, evidence-based, objective datafrom whole-life experiences to predict why you are who you are, andapplies this knowledge toward a fuller understanding of how to improveyour mental well-being. After registering at the YMI Health website,users gain access to a private, in-depth survey that applies machinelearning using a person's genetic expressions, childhood environment,habits, phobias, lived experiences and lifestyle. Upon completion ofthe questionnaire, YMI generates a personalized graphic reportpredicting a person's predisposition for seven mental conditions,including anxiety, depression, posttraumatic stress disorder,obsessive compulsive disorder, alcoholism and personality disorders,both current and forward in time. The downloadable report may be usedfor reference as the user considers changes to their lifestyle thatmay help improve their mental well-being and mental health journey.The service also helps connect users with therapists who are preparedto help with next steps, providing further clarity and treatment asrequired.
FOR FURTHER INFORMATION, PLEASECONTACT:
NDATALYZE CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimdurward72@gmail.com
This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available.
The information in this news releaseincludes certain information and statements about management's view offuture events, expectations, plans and prospects that constituteforward looking statements. These statements are based uponassumptions that are subject to significant risks and uncertainties.Because of these risks and uncertainties and as a result of a varietyof factors, the actual results, expectations, achievements orperformance may differ materially from those anticipated and indicatedby these forward looking statements. Any number of factors could causeactual results to differ materially from these forward-lookingstatements as well as future results. Although the Corporationbelieves that the expectations reflected in forward looking statementsare reasonable, it can give no assurances that the expectations of anyforward-looking statements will prove to be correct. Except asrequired by law, the Corporation disclaims any intention and assumesno obligation to update or revise any forward looking statements toreflect actual results, whether as a result of new information, futureevents, changes in assumptions, changes in factors affecting suchforward looking statements or otherwise.
Neither the Canadian SecuritiesExchange nor its Regulation Services Provider (as that term is definedin the policies of the Canadian Securities Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
Copyright (c) 2023 TheNewswire - All rights reserved.